Physician profile
Deane Franso
NPI 1407122906
$1,072.17
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.25 · 2021: $188 · 2022: $171 · 2023: $238 · 2024: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $168.71 | 2021-2024 | Arexvy, Nucala, Trelegy Ellipta |
| Inspire Medical Systems, INC. | $163.18 | 2024 | Inspire |
| Mylan Specialty L.P. | $151.05 | 2020-2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $149.02 | 2021-2024 | Tezspire, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.62 | 2021-2022 | |
| Grifols USA, LLC | $62.57 | 2021-2024 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $45.22 | 2024 | Opsumit |
| Inogen, INC. | $45.13 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Harmony Biosciences LLC | $44.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.13 | 2022-2023 | Glassia |
| Philips North America LLC | $24.63 | 2022 | |
| Genentech USA, INC. | $19.76 | 2024 | Xolair |
| Insmed, INC. | $18.66 | 2022 | |
| Genzyme Corporation | $17.97 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.94 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.78 | 2023 | Tezspire |
| Electromed, INC. | $13.63 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deane Franso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.